BTG Pactual Global Asset Management’s Pacific Biosciences PACB Stock Holding History

BTG Pactual Global Asset Management’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-239,241	Closed	-$1.23M	–	105
2019 Q3	$1.23M	Buy	239,241 +92,400	+63%	+$517K	0.55%	37
2019 Q2	$888K	Sell	146,841 -158,725	-52%	-$1.11M	0.22%	49
2019 Q1	$2.21M	Buy	305,566 +152,166	+99%	+$1.1M	0.84%	23
2018 Q4	$1.14M	Buy	+153,400	New	+$972K	0.98%	29

Other funds holding PACB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

WIC

Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BTG Pactual Global Asset Management's PACB Position: Q4 2019 in Review

BTG Pactual Global Asset Management sold out of Pacific Biosciences (PACB) in Q4 2019, closing a stake of 239,241 shares — an estimated $1.23M sold.

BTG Pactual Global Asset Management first reported a position in PACB in Q4 2018 and held it in 4 quarters. The position peaked at $2.21M in Q1 2019. 143 funds tracked by Wall St. Rank hold PACB as of Q4 2019.

BTG Pactual Global Asset Management reported no remaining Pacific Biosciences position as of Q4 2019 after selling out during the quarter.
BTG Pactual Global Asset Management sold 239,241 Pacific Biosciences shares in Q4 2019, an estimated $1.23M.
BTG Pactual Global Asset Management first reported a position in Pacific Biosciences in Q4 2018 and held it in 4 quarters.
BTG Pactual Global Asset Management's Pacific Biosciences position peaked at $2.21M in Q1 2019.
143 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2019.

Based on BTG Pactual Global Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.